New call warrants tracking top tech index performer Bilibili and worst performer Trip
🆕Macquarie has listed new call warrants $Bilibili MB eCW260602(QZTW.SI)$ (https://warrants.com.sg/tools/livematrix/QZTW) and $Trip MB eCW260602(HZXW.SI)$ (https://warrants.com.sg/tools/livematrix/HZXW) tracking the respective new underlyings of Bilibili and Trip.com
🦭Both stocks have been experiencing high share price volatility over the past month
5⃣ $BILIBILI-W(09626)$ : the stock is currently on a five-day losing streak, pulling back 14% from its 4-year high of HKD 281 on 28 January
📉Bilibili is dragged lower as concerns that China could raise the VAT tax on the internet sector weighed on Chinese tech stock sentiment
🔝Despite the sharp pullback over the past week, Bilibili remains one of the top index performers on the Hang Seng Tech Index (HSTECH) with year-to-date gains of 25% as of 11AM
🎮The highly anticipated game 'Sanguo: Ncard' is expected to launch in early 2026, which could serve as a catalyst for mobile game revenue
👍Analysts have expressed optimism that Sanguo's overseas launch may help Bilibili's game revenue revert to growth in the second half of 2026.
🕹Other games such as 'Escape from Duckov' sold over 3 million copies in 30 days and is expected to contribute positively to 4Q revenue and profit (Bloomberg)
🗓Bilibili is scheduled to report 4Q earnings on 20 February
🔻 $TRIP.COM-S(09961)$ the stock experienced its biggest one-day plunge of 22% on 15 January, a day after the company said that it received a notice of investigation from China's State Administration for Market Regulations for potential violations of the Anti-Monopoly Law
↗The stock subsequently rebounded as much a 8.6% over the next 8 days, but is currently trading 0.7% lower compared its 15 January price level to HKD 456 as of 11AM today
🥀Trip is currently one of worst performing index stocks on the HSTECH with year to date losses of 18% as of 11AM today
☁While Trip's business operations remain normal, the investigation which is expected to take 3-6 months to complete - will remain a share price overhang for the company.
🗓Trip is scheduled to report 4Q earnings on 24 February. Some analysts have experienced optimism on upbeat results with the company benefiting from enhanced supply chain capabilities and operating efficiency gains in both domestic and outbound business
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
